Hemodialys and Peritoneal Dialysis Market is Anticipated to a Significant CAGR of 6.1% during Forecasts 2022 to 2032

The hemodialys and peritoneal dialysis market is expected to grow at a CAGR of 6.1%, from USD 81.8 billion in 2022 to USD 148.1 billion by 2032. The increasing number of ESRD patients, the rising prevalence of diabetes and hypertension, the scarcity of organ donors and the risks associated with transplants, technological advancements, and initiatives by hemodialys and peritoneal dialysis market leaders to introduce advanced products and services are driving growth in this hemodialys and peritoneal dialysis market.

However, the dangers and difficulties connected with dialysis, as well as product recalls, are anticipated to limit the hemodialys and peritoneal dialysis market’s development to some extent. The coronavirus pandemic is now posing a number of issues to clinical healthcare practitioners and patients worldwide.

The increase in the number of COVID cases, as well as the severity rate, is expected to result in an increase in the incidence of renal injury. The global need for renal replacement fluids has expanded dramatically as a result of the epidemic. When compared to previous US populations, the need for RRT among COVID-19 patients has grown fivefold.

The progressive transition toward home hemodialys therapy prior to the pandemic, as well as worries about the spread of COVID-19 infection, has significantly increased patient interest in HD treatment. During the pandemic, this factor is expected to increase the use of home hemodialys supplies.

Emerging economies including China, India, Brazil, and Mexico are likely to provide major growth prospects for hemodialys and peritoneal dialysis providers. According to the US Renal Data System, Taiwan and Malaysia have the highest incidence of treated ESRD in the 45–65 and 75 years age group.

Get a Sample Copy of Report @

To capitalise on the considerable growth prospects in emerging regions, firms are increasingly focused on strategic development agreements/partnerships with regional/domestic players, geographical expansions, and acquisitions.

Furthermore, government support for ESRD therapy, the development of home/nocturnal dialysis, and the expanding number of dialysis clinics are fueling the expansion of the hemodialys and peritoneal dialysis market in developing nations.

The leading causes of death among dialysis patients are heart illnesses (arrhythmic mechanisms or sudden cardiac arrest) and vascular access-related issues such as bleeding and infection, low blood pressure, nausea, hernia, hepatitis (B & C), and anaemia.

Peritonitis is a frequent peritoneal dialysis complication caused by contamination of peritoneal dialysate or tubing with pathogenic skin germs or by catheter-related illnesses. Peritonitis kills 16% of Parkinson’s disease patients in North America each year. This restricts the use of dialysis techniques.

The hemodialys and peritoneal dialysis markets are dominated by North America. European is gaining momentum among the region’s enormous dialysis patient group. Factors such as a stronger reimbursement system in comparison to Europe and the Asia Pacific, the availability of professionals (nephrologists), and the presence of well-equipped dialysis clinics for patient treatment are pushing the hemodialys and peritoneal dialysis market.

Factors such as the growing preference for peritoneal dialysis and the rising use of home hemodialys (HHD) are driving the expansion of the hemodialys and peritoneal dialysis market.


  • In the type sector, Hemodialys from the Hemodialys and peritoneal dialysis market are anticipated to flourish at the quickest CAGR of 5.5% through 2032.
  • With a CAGR of 5.7% through 2032, Hospital Dialysis are predicted to grow significantly in the application sector of the Hemodialys and peritoneal dialysis market.
  • The market size for Hemodialys and peritoneal dialysis market in the United States is expected to reach US$ 49.4 Billion by 2032, growing at a CAGR of 6% during the research period.
  • China is anticipated to reach a market size of US$ 10.2 billion in Hemodialys and peritoneal dialysis by 2032, with a CAGR of 5.5% during the forecast period.
  • By 2032, South Korea is expected to reach a market size of US$ 5.3 Billion in Hemodialys and peritoneal dialysis, with a CAGR of 49% during the forecast period.

Ask Us Your Questions About This Report @


The major players in the global hemodialys and peritoneal dialysis market are Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International, Inc. (US), Nikkiso Co., Ltd. (Japan), B. Braun Melsungen AG (Germany), Asahi Kasei Corporation (Japan), DaVita Inc. (US), Nipro Corporation (Japan), Cantel Medical Corporation (US), Diaver (US).


  • Mar Cor (Cantel Medical Corporation) announced the release of their unique EON Portable Hemodialys Water System in 2021.
  • Fresenius Medical Care AG & Co. KGaA announced the release of a PVC-free peritoneal dialysis solution bag for home dialysis therapy in 2020.
  • Baxter International Inc. gained FDA clearance for a De Novo application for Theranova dilayzers designed to provide enhanced hemodialys (HDx) treatment in 2020.

Related Links –




Contact Us

Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers
United Arab Emirates

Leave a comment

Your email address will not be published. Required fields are marked *